Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on March 17, 2025

Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

--Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease-- --Data Presented at the 2025 Muscular Dystrophy Association (MDA) Conference-- SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: …

Alpha Bites Gummies: The Science, Ingredients, and Real User Experiences Behind This Natural Male Vitality Formula

Alpha Bites Gummies: The Science, Ingredients, and Real User Experiences Behind This Natural Male Vitality Formula

LAKELAND, Fla., March 17, 2025 (GLOBE NEWSWIRE) -- The wellness industry is witnessing a surge in science-backed, natural solutions for male vitality, and Alpha Bites has quickly risen to prominence as a frontrunner in this space. Combining ancient herbal …

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for …

PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer

PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer

Press release PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in …

Curia kündigt Erweiterung des globalen Netzwerks steriler Abfüllanlagen an

Curia kündigt Erweiterung des globalen Netzwerks steriler Abfüllanlagen an

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Unternehmen für Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute Expansionspläne für seinen Standort in Glasgow, Großbritannien, bekannt und …

Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites

Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK facility and provided updates on the ongoing expansion …

Curia anuncia expansión de red global de locales de llenado y acabado estéril

Curia anuncia expansión de red global de locales de llenado y acabado estéril

ALBANY, Nueva York, March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder en investigación, desarrollo y fabricación por contrato (CDMO), anunció hoy planes de expansión para sus instalaciones en Glasgow, Reino Unido, y …

Curia annonce l’extension de son réseau mondial de sites de remplissage et de finition stériles

Curia annonce l’extension de son réseau mondial de sites de remplissage et de finition stériles

ALBANY, État de New York, 17 mars 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation leader du domaine de la recherche, du développement et de la fabrication sous contrat, dévoile ce jour les projets d’agrandissement de son site de …

Curia הכריזה על הרחבות ברשת אתרי המילוי והגימור הסטריליים הגלובליים שלה

Curia הכריזה על הרחבות ברשת אתרי המילוי והגימור הסטריליים הגלובליים שלה

אולבני, ניו יורק, March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (קוריה), חברה מובילה למחקר, פיתוח וייצור לפי חוזים, הכריזה היום על תוכניות הרחבה למתקן שלה בגלזגו, בריטניה וסיפקה עדכונים על ההתרחבות המתמשכת באלבקרקי, ניו מקסיקו. מתקן המילוי והגימור …

Curia Mengumumkan Ekspansi ke Jaringan Global Fasilitas Fill-Finish Steril

Curia Mengumumkan Ekspansi ke Jaringan Global Fasilitas Fill-Finish Steril

ALBANY, New York, March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak, hari ini mengumumkan rencana ekspansi ke fasilitasnya di Glasgow, Inggris Raya, dan memberikan …

キュリア (Curia)、無菌充填仕上げ施設のグローバルネットワーク拡充を発表

キュリア (Curia)、無菌充填仕上げ施設のグローバルネットワーク拡充を発表

ニューヨーク州オールバニ発 , March 17, 2025 (GLOBE NEWSWIRE) -- 研究開発・製造業務受託機関のリーダーであるキュリア・グローバル (Curia Global, Inc.)(キュリア) は本日、英国グラスゴー施設の拡張計画を発表し、ニューメキシコ州アルバカーキで進行中の拡張プロジェクトの最新情報を提供した。 …

Curia, 멸균 충전-마감 생산 및 제조시설 글로벌 확장 계획 발표

Curia, 멸균 충전-마감 생산 및 제조시설 글로벌 확장 계획 발표

올버니, 뉴욕, March 17, 2025 (GLOBE NEWSWIRE) -- 의약품 위탁 연구 및 개발, 제조(CDMO) 분야 선도 기업인 큐리아(Curia)가   영국 글래스고 (Glasgow) 시설의 확장 계획을 발표하면서 뉴멕시코주 앨버커키 (Albuquerque)에서 진행 중인 시설 확장 현황에 대한 업데이트 정보도 공개했다. 글래스고에 소재한 Curia의 멸균 충전-완성 시설에는 고독성 용량을 비롯해 광범위한 의약품에 적합한 통합된 격리기 기반 …

Curia Mengumumkan Perluasan Rangkaian Global Tapak Kemasan Isian Steril

Curia Mengumumkan Perluasan Rangkaian Global Tapak Kemasan Isian Steril

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), sebuah organisasi penyelidikan, pembangunan dan pembuatan kontrak terkemuka, hari ini mengumumkan rancangan untuk perluasan ke kemudahannya di Glasgow, UK serta memberikan kemas …

Curia Anuncia Expansão da Rede Global de Locais de Processamento Final Estéril

Curia Anuncia Expansão da Rede Global de Locais de Processamento Final Estéril

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- A Curia Global, Inc. (Curia), uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje planos de expansão de suas instalações em Glasgow, Reino Unido, e forneceu …

Curia ประกาศขยายโรงงานในเครือข่ายโรงงานระดับโลกสำหรับการบรรจุและการตกแต่งแบบปลอดเชื้อ

Curia ประกาศขยายโรงงานในเครือข่ายโรงงานระดับโลกสำหรับการบรรจุและการตกแต่งแบบปลอดเชื้อ

ออลบานี นิวยอร์ก, March 17, 2025 (GLOBE NEWSWIRE) -- วันนี้ Curia Global, Inc. (Curia) ซึ่งเป็นองค์กรชั้นนำด้านการวิจัย การพัฒนา และการผลิตตามสัญญา ได้ประกาศแผนการขยายโรงงานที่กลาสโกลว์ สหราชอาณาจักร …

Curia宣布扩大全球无菌灌装产能

Curia宣布扩大全球无菌灌装产能

纽约州奥尔巴尼, March 17, 2025 (GLOBE NEWSWIRE) -- 全球领先的合同研究、开发和制造企业 Curia Global, Inc. (Curia) 今日宣布英国格拉斯哥 (Glasgow) 工厂扩建计划,并通报了新墨西哥州阿尔伯克基 (Albuquerque) 工厂持续扩建项目的最新进展。 Curia计划在格拉斯哥无菌灌装工厂新增一条集成隔离器的西林瓶灌装生产线,并新购入一台适用于强效药品等多种药物产品的冻干机,将GMP批次产量提高一倍以上。 格拉斯哥工厂素以抗体药物偶联物 ( …

Curia 宣佈擴展全球無菌灌裝生產地點的網絡

Curia 宣佈擴展全球無菌灌裝生產地點的網絡

奧爾巴尼,紐約州, March 17, 2025 (GLOBE NEWSWIRE) -- 頂尖的合約研究、開發及製造企業 Curia Global, Inc. (Curia) 今天宣佈擴展其英國格拉斯哥工廠的計劃,並就新墨西哥州阿爾伯克基進行中的擴張計劃披露最新進展。 Curia 位於格拉斯哥的無菌灌裝工廠將會增加一條以隔離器為基礎的整合式小藥瓶灌裝線及冷凍乾燥機,適用於包括高效能藥物在內的多種藥物製品,比目前 GMP 批次規模增加一倍以上。 Curia 已憑著其抗體偶聯藥物 (antibody drug …

VitalHub Announces Q4 2024 Conference Call Date

VitalHub Announces Q4 2024 Conference Call Date

TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release its financial results for its fourth quarter 2024 ended December 31, 2024, after market close on …

Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering

Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering

XI’AN, China, March 17, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has priced …

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs, except for the bladder and kidney as expected …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service